COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS

被引：8

作者：

Genc, S. ^{[1
]}

Evren, B. ^{[1
]}

Bozbay, A. ^{[1
]}

Aydin, E. S. ^{[1
]}

Genc, O. ^{[2
]}

Sahin, I. ^{[1
]}

机构：

[1] Inonu Univ, Fac Med Res Hosp, Endocrinol & Metab, Malatya, Turkey

[2] Malatya Training & Res Hosp, Internal Med, Malatya, Turkey

来源：

ACTA ENDOCRINOLOGICA-BUCHAREST | 2021年 / 17卷 / 04期

关键词：

Covid-19; Type; 1; Diabetes; Diabetic Ketoacidosis; INFECTIONS;

D O I：

10.4183/aeb.2021.532

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.

引用

页码：532 / 536

页数：5

共 18 条

[1]

[Anonymous], 2020, COVID 19 PANDEMI DIY

[2] Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak? [J].

Caruso, Paola ;

Longo, Miriam ;

Esposito, Katherine ;

Maiorino, Maria Ida .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164

[3] Why is hyperglycaemia worseningCOVID-19 and its prognosis? [J].

Ceriello, Antonio ;

De Nigris, Valeria ;

Prattichizzo, Francesco .

DIABETES OBESITY & METABOLISM, 2020, 22 (10) :1951-1952

[4] Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus [J].

Chee, Ying Jie ;

Ng, Shereen Jia Huey ;

Yeoh, Ester .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 164

[5] Viral infections in type 1 diabetes mellitus - why the β cells? [J].

de Beeck, Anne Op ;

Eizirik, Decio L. .

NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (05) :263-273

[6] High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care [J].

Goldman, Nina ;

Fink, Douglas ;

Cai, James ;

Lee, Yun-Ni ;

Davies, Zoe .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166

[7]

Inde Zintis, 2020, bioRxiv, DOI 10.1101/2020.09.13.276923

[8] Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany [J].

Kamrath, Clemens ;

Moenkemoeller, Kirsten ;

Biester, Torben ;

Rohrer, Tilman R. ;

Warncke, Katharina ;

Hammersen, Johanna ;

Holl, Reinhard W. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (08) :801-804

[9] Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus [J].

Kuhn, JH ;

Li, W ;

Choe, H ;

Farzan, M .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) :2738-2743

[10] Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study [J].

Lonnrot, Maria ;

Lynch, Kristian F. ;

Larsson, Helena Elding ;

Lernmark, Ake ;

Rewers, Marian J. ;

Torn, Carina ;

Burkhardt, Brant R. ;

Briese, Thomas ;

Hagopian, William A. ;

She, Jin-Xiong ;

Simell, Olli G. ;

Toppari, Jorma ;

Ziegler, Anette-G. ;

Akolkar, Beena ;

Krischer, Jeffrey P. ;

Hyoty, Heikki .

DIABETOLOGIA, 2017, 60 (10) :1931-1940

← 1 2 →